BINITA PAREKH: Open Payments
NPI 1194000125 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 13 payments from 7 companies in 2025. Trend: 2023 $409 · 2024 $485 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $122 |
| Incyte Corporation | 4 | $95 |
| Janssen Biotech, Inc. | 2 | $68 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| Legend Biotech USA Inc. | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Melinta Therapeutics, LLC | 1 | $22 |
Products named: CERDELGA, CARVYKTI, JAKAFI, ULTOMIRIS, PREVYMIS, Rezzayo.
Industry payments across AL — which companies pay providers there.
